You searched for precision medicine - Page 9 of 65

News and Trends 3 Oct 2022

Alexion, AstraZeneca Rare Disease to acquire genomic medicine company LogicBio Therapeutics

…and expertise in pre-clinical development to support Alexion’s growth in genomic medicines. Fred Chereau, president and chief executive officer at LogicBio, said: “We are excited about the opportunity to bring…

October 3, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Jul 2022

Stroke drug given priority medicine status by European Medicines Agency

A biotech company developing drugs for cardiovascular emergencies, specifically strokes, has received priority medicines status from the European Medicines Agency (EMA) for its drug candidate, glenzocimab. Paris-based Acticor Biotech made…

July 22, 2022 - 2 minutesmins - By Liza Laws

In Depth 7 Jun 2021

The Post-Covid Future of AI for Drug Development

…causing severe side effects. AI offers a high level of precision to the complicated and time-consuming discovery phase in drug development. That precision leads to faster development timelines and a…

June 7, 2021 - 11 minutesmins - By Matthew Williams

News and Trends 12 Sep 2024

Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges

…may see reduced investment. Precision medicine and rare disease therapies, which target smaller patient populations, could become less economically viable under the new pricing regime. Complex biologics, despite their longer…

September 12, 2024 - 7 minutesmins - By Jules Adam

News and Trends 12 Dec 2024

Top biotech deals of November 2024

…part of this wintry time. Moreover, biotech deals in antibody-drug conjugates, small molecules, antibody therapies, GLP-1 agonists, and precision medicine stood out in November 2024. Table of contents Top M&As…

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 23 May 2024

10 notable pharma and biotech venture capital arms

…efficacy of radiotherapy in oncology. Plus, precision neuromedicine company Rapport Therapeutics was spun out of JJDC (as well as Third Rock Ventures and ARCH) in March 2023 with a $100…

May 23, 2024 - 10 minutesmins - By Willow Shah-Neville

Podcast 9 Jun 2023

Beyond Biotech podcast 49

This week, we have a conversation about precision medicine with Tero Silvola, CEO at BC Platforms. We also discuss the acquisition of 4Pharma. The acquisition expands BCP’s global service offering…

June 9, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 13 May 2025

Nine biotech companies in Montreal to keep an eye on in 2025

…in preclinical and discovery stages. Earlier this month, the company raised money for a seed round, according to Crunchbase. Giiant Pharma Technology: Precision medicine Lead candidate: GT-2108 for gut disorders…

May 13, 2025 - 11 minutesmins - By Roohi Mariam Peter

diabetes chronic kidney disease farxiga astraZeneca

News and Trends 8 Jun 2021

Farxiga’s Approval Fuels Chronic Kidney Disease Comeback

Until this year, there were no effective treatments for chronic kidney disease. However, the recent approval of AstraZeneca’s Farxiga alongside clinical breakthroughs and advances in precision medicine are causing the…

June 8, 2021 - 5 minutesmins - By Jonathan Smith

Interview 13 Feb 2019

Embracing Risk to Succeed in Biotech

…of the company. The investment firm focuses on several key areas where it can fully exploit its high risk-high reward strategy, including precision medicine, neurodegenerative and immuno-oncology. Today these are…

February 13, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

In Depth 3 Aug 2023

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

…has on addressing the fundamental challenges facing laboratory medicine, and on opening new opportunities to deliver precision care. Proscia is helping to lead that transformation,” said Buchbinder. Echoing Buchbinder’s thoughts,…

August 3, 2023 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 7 May 2025

Top biotech deals of April 2025

…the agreement, Tempus will draw in $200 million in data licensing and model development fees. RNA drugs, antibodies, and precision medicine boost biotech deals in April 2025 Lilly engaged in…

May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: precision medicine

Alexion, AstraZeneca Rare Disease to acquire genomic medicine company LogicBio Therapeutics

Stroke drug given priority medicine status by European Medicines Agency

The Post-Covid Future of AI for Drug Development

Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges

Top biotech deals of November 2024

10 notable pharma and biotech venture capital arms

Beyond Biotech podcast 49

Nine biotech companies in Montreal to keep an eye on in 2025

Farxiga’s Approval Fuels Chronic Kidney Disease Comeback

Embracing Risk to Succeed in Biotech

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

Top biotech deals of April 2025

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!